Pharmaceuticals

Prescription Pain Medication Industry Overview 2025: Growth Projections and Market Trends

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Prescription Pain Medication Market Covering 2025–2034?

The prescription pain medication market size has shown steady expansion over recent years. It is forecast to rise from $73.59 billion in 2024 to $77.22 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.9%. The growth observed in the past can be attributed to the escalating prevalence of chronic pain, an increasing volume of surgical procedures, a heightened focus on palliative care, and the rising incidence of musculoskeletal disorders.

The prescription pain medication market size is anticipated to experience substantial growth over the next few years. It is projected to attain a valuation of $95.11 billion by 2029, progressing at a compound annual growth rate (CAGR) of 5.3%. This expansion during the forecast period is fueled by the increasing demand for personalized medicine, a heightened focus on post-traumatic pain management, the rising adoption of telemedicine for pain management, a growing number of patients seeking opioid alternatives, and the increasing prevalence of neuropathic pain. Key trends expected in this period include the development of non-opioid pain alternatives, the integration of digital health solutions, innovations in targeted pain therapies, the formulation of combination pain medications, and advancements in non-addictive pain medications.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24385&type=smp

Which Factors And Drivers Are Influencing The Prescription Pain Medication Market In 2025?

The rising incidence of arthritis is projected to fuel the expansion of the prescription pain medication market moving ahead. Arthritis involves inflammation in one or multiple joints, leading to discomfort, edema, rigidity, and restricted movement. The growing prevalence of this condition is largely attributable to obesity, as surplus body weight puts extra strain on joints, especially the knees, thereby encouraging inflammation. Prescription pain medications assist in managing arthritis by easing inflammation and pain, thereby allowing improved joint functionality and enhancing the general well-being of individuals suffering from it. For example, in March 2023, data from the Office for Health Improvement and Disparities, a UK-based government department, indicated that in 2022, 17.6% of individuals aged 16 and over experienced arthritis or a persistent back or joint issue, an increase from 17.0% in 2021. Consequently, the rising occurrence of autoimmune disorders is propelling the growth of the prescription pain medications market.

What Are The Major Segments Identified In The Prescription Pain Medication Market?

The prescription pain medication market covered in this report is segmented –

1) By Type: Prescription Non-Steroidal Anti-Inflammatory Drugs, Opioids, Anti-Epileptic Medicines, Antidepressants, Other Types

2) By Route Of Administration: Oral, Injectable, Transdermal, Other Route Of Administrations

3) By Application: Neuropathic Pain, Cancer Pain, Post-Operative Pain, Other Applications

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Prescription Non-Steroidal Anti-Inflammatory Drugs: COX-2 Inhibitors, Traditional Non-Steroidal Anti-Inflammatory Drugs, Combination Non-Steroidal Anti-Inflammatory Drugs

2) By Opioids: Strong Opioids, Mild Opioids, Opioid Combination Medications

3) By Anti-Epileptic Medicines: Sodium Channel Blockers, Gamma-Aminobutyric Acid Modulators, Glutamate Inhibitors

4) By Antidepressants: Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants, Serotonin-Norepinephrine Reuptake Inhibitors, Other Antidepressants

5) By Other Types: Muscle Relaxants, Topical Pain Medications, Corticosteroids

Which Trends Are Impacting The Prescription Pain Medication Market?

Major companies operating in the prescription pain medication market are focusing on developing alternative therapies, such as non-opioid painkillers, to address rising concerns over opioid addiction and enhance patient safety. These non-opioid medications provide pain relief without the addictive risks of opioids, offering more secure and effective options for long-term pain management while lowering the potential for addiction and overdose. For instance, in January 2025, Vertex Pharmaceuticals Incorporated, a US-based biotechnology company, received approval from the U.S. Food and Drug Administration (FDA), a US-based government agency, for JOURNAVX, which is a first-in-class non-opioid oral medication. This medication works by selectively blocking NaV1.8 sodium channels in peripheral nerves to inhibit pain signals, without central nervous system involvement, providing effective acute pain relief without addictive potential. It offers clinically meaningful pain reduction, as demonstrated by Phase 3 trials in abdominoplasty and bunionectomy with a twice-daily dosing regimen, and is not a controlled substance, thereby addressing a critical need for safer acute pain management.

Which Major Industry Participants Are Leading The Prescription Pain Medication Market Growth?

Major companies operating in the prescription pain medication market are Mallinckrodt Public Limited Company, Pfizer Inc., Johnson And Johnson, Merck And Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline Public Limited Company, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Mylan N.V., Sandoz, Inc, Bausch Health Companies Inc., Purdue Pharma L.P., Endo International Plc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/prescription-pain-medication-global-market-report

What Are The Regional Market Dynamics Impacting The Prescription Pain Medication Industry?

North America was the largest region in the prescription pain medication market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prescription pain medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Prescription Pain Medication Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24385&type=smp

Browse Through More Reports Similar to the Global Prescription Pain Medication Market 2025, By The Business Research Company

Omega 3 Prescription Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/omega-3-prescription-drugs-global-market-report

Joint Pain Injections Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

Paint Rollers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/paint-rollers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795